SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
06-Mar-23 11:36 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition | 57,766 | -- | -- | (42%) 138.36K to 80.59K | |
06-Mar-23 11:36 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 06-Mar-23 | Disposition (change in control) | 80,595 | -- | -- | (100%) 80.59K to 0 | |
16-Feb-23 8:48 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 15-Feb-23 | Private Sale (Planned) | 3,762 | $8.34 | $31,375.10 | (2%) 176.82K to 173.06K | |
31-Jan-23 8:28 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 30-Jan-23 | Private Sale (Planned) | 10,106 | $8.35 | $84,385.10 | (5%) 186.93K to 176.82K | |
09-Jan-23 4:13 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jan-23 | Private Sale (Planned) | 2,893 | $7.25 | $20,974.20 | (2%) 189.82K to 186.93K | |
16-Feb-22 8:01 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 14-Feb-22 | Market Sale (Planned) | 3,762 | $3.09 | $11,624.60 | (2%) 193.58K to 189.82K | (9%) |
01-Feb-22 4:03 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 28-Jan-22 | Grant | 110,500 | -- | -- | 133% 83.08K to 193.58K | |
07-Jan-22 4:17 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 05-Jan-22 | Market Sale (Planned) | 2,894 | $3.19 | $9,231.86 | (3%) 85.98K to 83.08K | (6%) |
17-Aug-21 10:00 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 16-Aug-21 | Market Sale (Planned) | 8,086 | $3.28 | $26,522.10 | (9%) 94.06K to 85.98K | (< 1%) |
17-Feb-21 9:27 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 16-Feb-21 | Market Sale (Planned) | 3,763 | $7.32 | $27,545.20 | (4%) 97.83K to 94.06K | 45% |
07-Jan-21 4:35 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 05-Jan-21 | Grant | 21,700 | -- | -- | 29% 76.13K to 97.83K | |
19-Aug-20 5:44 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 17-Aug-20 | Market Sale (Planned) | 4,354 | $10.37 | $45,151.00 | (5%) 80.48K to 76.13K | 61% |
19-Feb-20 4:04 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 14-Feb-20 | Grant | 28,216 | -- | -- | 54% 52.27K to 80.48K | |
19-Aug-19 6:12 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 15-Aug-19 | Grant | 31,100 | -- | -- | 147% 21.16K to 52.27K | |
02-Apr-19 4:15 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 31-Mar-19 | Payment of Exercise | 8,835 | $12.07 | $106,638.00 | (29%) 30.0K to 21.16K | 66% |
19-Apr-18 4:07 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 17-Apr-18 | Market Sale (Planned) | 10,582 | $20.18 | $213,510.00 | (26%) 40.58K to 30.0K | 80% |
03-Apr-18 4:20 PM View: | Concert Pharmaceuticals, Inc. (CNCE) | 31-Mar-18 | Payment of Exercise | 4,418 | $22.90 | $101,172.00 | (7%) 60.0K to 55.58K | 82% |
10-Jul-17 7:09 AM View: | Concert Pharmaceuticals, Inc. (CNCE) | 06-Jul-17 | Grant | 60,000 | -- | -- | 100% 0 to 60.0K | |
02-Apr-13 5:28 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 29-Mar-13 | Grant | 43,750 | $4.42 | $193,375.00 | 233% 18.75K to 62.49K | (78%) |
08-Feb-13 4:33 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 07-Feb-13 | Grant | 17,795 | -- | -- | 1873% 0.95K to 18.75K | |
27-Dec-12 4:19 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 26-Dec-12 | Market Sale (Planned) | 4,558 | $4.90 | $22,315.50 | (83%) 5.51K to 0.95K | 81% |
29-Aug-12 5:39 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 27-Aug-12 | Market Sale (Planned) | 10,000 | $4.14 | $41,364.00 | (64%) 15.51K to 5.51K | 77% |
08-Jun-12 4:56 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 06-Jun-12 | Market Sale (Planned) | 46,222 | $0.34 | $15,627.70 | (23%) 204.02K to 157.8K | 72% |
14-May-12 4:38 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 10-May-12 | Grant | 100,000 | -- | -- | 96% 104.02K to 204.02K | |
26-Mar-12 5:47 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 23-Mar-12 | Grant | 46,222 | -- | -- | 80% 57.8K to 104.02K | |
21-Jan-11 4:39 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 19-Jan-11 | Grant | 45,582 | -- | -- | 373% 12.22K to 57.8K | |
18-Dec-09 6:46 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 18-Dec-09 | Market Sale | 12,408 | $2.13 | $26,390.60 | (50%) 24.62K to 12.21K | 95% |
18-Dec-09 6:46 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 17-Dec-09 | Market Sale | 4,284 | $2.20 | $9,427.80 | (15%) 28.91K to 24.62K | 95% |
18-Dec-09 6:46 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 16-Dec-09 | Market Sale | 7,732 | $2.41 | $18,611.70 | (21%) 36.64K to 28.91K | 96% |
26-Feb-09 5:42 PM View: | Alexza Pharmaceuticals Inc. (ALXA) | 24-Feb-09 | Grant | 24,419 | -- | -- | 200% 12.22K to 36.64K |